Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.58 0.00%   SPY: 165.74 0.00%
Quote Spy VRTX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Vertex Pharmaceuticals (VRTX)

@ Jun-18
Click the portfolio to add VRTX:
Close [X]
+ Add VRTX to Portfolio
  
  Last Trade: $78.80 0.00 (0.00%)
  Volume:
       
  Avg Volume: 1,847,982
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.00 - 0.00
  Open: 0.00
  Previous Close: 78.80
  52-wk Range: 38.44 - 87.47
  Market Cap: 17.2B
  P/E: -33.4
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (+1.4%)
Cancer Stocks (+1.3%)
Spy VRTX

? Pro holders
? Member holders
? Items submitted
Additional VRTX resources



Customize Links
To see which Pros and tickerspy members own VRTX Sign up now
Latest VRTX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Vertex Completes Redemption of Convertible Senior Subordinated Notes
VRTX  
Linked by BusinessWire - June 18, 08:30AM from (www.businesswire.com)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has completed its previously announced call for  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains
CELG  BIIB  VRTX  GILD  ALXN  ONXX  OREX  TSRX  
Linked by 24/7 Wall St. - June 13, 08:15AM from (247wallst.com)
The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest Falls in Vertex, Rises in Biogen Idec
BMY  PFE  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com - June 12, 01:29PM from (www.benzinga.com)
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB), saw the most significant rise in short interest  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
BMY  JNJ  MRK  VRTX  GILD  ABBV  
Linked by Bloomberg - June 03, 03:37AM from (www.bloomberg.com)
Jean-Michel Pawlotsky has déjà vu.
The doctor in the town of Creteil, just outside Paris, is telling hepatitis C  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest in Vertex Rises, in Biogen Idec Falls
BMY  PFE  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com - May 29, 01:19PM from (www.benzinga.com)
Among biotech and emerging pharmaceutical companies, Regeneron Pharmaceuticals (NASDAQ: REGN) and Vertex Pharmaceuticals  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
$307,000-a-year Vertex Drug: Billions in Sales?
VRTX  
Linked by YCHARTS - May 20, 12:50PM from (ycharts.com)
Here is a question that is likely to plague the pharmaceutical industry and patient advocacy groups for some time to come:  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
VRTX  
Linked by BusinessWire - May 17, 08:30AM from (www.businesswire.com)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it has called for redemption of its outstanding $400.0  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Deutsche Bank Firm on Biotech Stocks to Buy
AMGN  CELG  REGN  BIIB  VRTX  GILD  ALXN  ONXX  DB  
Linked by 24/7 Wall St. - May 15, 08:10AM from (247wallst.com)
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest in Vertex Rises, in Celgene Falls
BMY  PFE  JNJ  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  
Linked by Benzinga.com - May 11, 10:45AM from (www.benzinga.com)
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
S&P Highlights Biotech ETFs
ABT  JNJ  AMGN  CELG  BIIB  VRTX  GILD  NPSP  IBB  BBH  PJP  XBI  
Linked by Benzinga.com - May 10, 07:39AM from (www.benzinga.com)
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 27



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource